請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78604
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 牟中原(Chung-Yuan Mou) | |
dc.contributor.author | Tzu-Ting Tseng | en |
dc.contributor.author | 曾子庭 | zh_TW |
dc.date.accessioned | 2021-07-11T15:06:47Z | - |
dc.date.available | 2022-08-23 | |
dc.date.copyright | 2019-08-23 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-08-13 | |
dc.identifier.citation | 1. Gu, F. X.; Karnik, R.; Wang, A. Z.; Alexis, F.; Levy-Nissenbaum, E.; Hong, S.; Langer, R. S.; Farokhzad, O. C., Targeted nanoparticles for cancer therapy. Nano Today 2007, 2 (3), 14-21.
2. Aslan, B.; Ozpolat, B.; Sood, A. K.; Gabriel, L. B., Nanotechnology in cancer therapy. Journal of Drug Targeting 2013, 21 (10), 904-913. 3. Bharali, D. J.; Khalil, M.; Gurbuz, M.; Simone, T. M.; Mousa, S. A., Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. International Journal of Nanomedicine 2009, 4, 1-7. 4. Brigger, I.; Dubernet, C.; Couvreur, P., Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews 2012, 64, 24-36. 5. Albanese, A.; Tang, P. S.; Chan, W. C. W., The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annual Review of Biomedical Engineering 2012, 14 (1), 1-16. 6. Benezra, M.; Penate-Medina, O.; Zanzonico, P. B.; Schaer, D.; Ow, H.; Burns, A.; DeStanchina, E.; Longo, V.; Herz, E.; Iyer, S.; Wolchok, J.; Larson, S. M.; Wiesner, U.; Bradbury, M. S., Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. Journal of Clinical Investigation 2011, 121 (7), 2768-2780. 7. Heinz, H.; Pramanik, C.; Heinz, O.; Ding, Y.; Mishra, R. K.; Marchon, D.; Flatt, R. J.; Irina, E. L.; Llop, J.; Moya, S.; Ziolo, R. F., Nanoparticle decoration with surfactants: molecular interactions, assembly, and applications. Surface Science Reports 2017, 72 (1), 1-58. 8. Lu, F.; Wu, S. H.; Hung, Y.; Mou, C. Y., Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 2009, 5 (12), 1408-1413. 9. Wu, S. H.; Hung, Y.; Mou, C. Y., Mesoporous silica nanoparticles as nanocarriers. Chemical Communications 2011, 47 (36), 9972-9985. 10. Chen, N. T.; Cheng, S. H.; Souris, J. S.; Chen, C. T.; Mou, C. Y.; Lo, L. W., Theranostic applications of mesoporous silica nanoparticles and their organic/inorganic hybrids. Journal of Materials Chemistry B 2013, 1 (25), 3128-3135. 11. LaMer, V. K.; Dinegar, R. H., Theory, production and mechanism of formation of monodispersed hydrosols. Journal of the American Chemical Society 1950, 72 (11), 4847-4854. 12. Wu, S. H.; Mou, C. Y.; Lin, H. P., Synthesis of mesoporous silica nanoparticles. Chemical Society Review 2013, 42 (9), 3862-3875. 13. Stöber, W.; Fink, A., Controlled growth of monodisperse silica spheres in micron size range. Journal of Colloid and Interface Science 1968, 26 (1), 62-69. 14. Lin, H. P.; Mou, C. Y., Structural and morphological control of cationic surfactant-templated mesoporous silica. Accounts of Chemical Research 2002, 35 (11), 927-935. 15. Suzuki, K.; Ikari, K.; Imai, H., Synthesis of silica nanoparticles having a well-ordered mesostructure using a double surfactant system. Journal of the American Chemical Society 2004, 126 (2), 462-463. 16. Huh, S.; Wiench, J. W.; Trewyn, B. G.; Song, S.; Pruski, M.; Lin, V. S. Y., Tuning of particle morphology and pore properties in mesoporous silicas with multiple organic functional groups. Chemical Communications 2003, (18), 2364-2365. 17. Huh, S.; Wiench, J. W.; Yoo, J. C.; Pruski, M.; Lin, V. S. Y., Organic functionalization and morphology control of mesoporous silicas via a co-condensation synthesis method. Chemistry of Materials 2003, 15 (22), 4247-4256. 18. Nel, A. E.; Mädler, L.; Velegol, D.; Xia, T.; Hoek, E. M.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M., Understanding biophysicochemical interactions at the nano–bio interface. Nature Materials 2009, 8 (7), 543-557. 19. Fang, J.; Nakamura, H.; Maeda, H., The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Advanced Drug Delivery Reviews 2011, 63 (3), 136-151. 20. Danhier, F.; Feron, O.; Preat, V., To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. Journal of Control Release 2010, 148 (2), 135-146. 21. Gu, M.; Wang, X.; Toh, T. B.; Chow, E. K., Applications of stimuli-responsive nanoscale drug delivery systems in translational research. Drug Discovery Today 2018, 23 (5), 1043-1052. 22. Gao, W.; Chan, J. M.; Farokhzad, O. C., pH-responsive nanoparticles for drug delivery. Mol Pharmaceut 2010, 7 (6), 1913-1920. 23. Mutalabisin, M. F.; Chatterjee, B.; Jaffri, J. M., pH-responsive polymers in drug delivery. Research Journal of Pharmacy and Technology 2018, 11 (11), 5115-5122. 24. Garzaran, M. G.; Manzano, M.; Regi, M. V., pH-responsive mesoporous silica and carbon nanoparticles for drug delivery. Bioengineering (Basel) 2017, 4 (1), 1-27. 25. Zheng, H.; Xing, L.; Cao, Y.; Che, S., Coordination bonding based pH-responsive drug delivery systems. Coordination Chemistry Reviews 2013, 257 (11-12), 1933-1944. 26. Unsoy, G.; Khodadust, R.; Yalcin, S.; Mutlu, P.; Gunduz, U., Synthesis of doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery. European Journal of Pharmaceutical Sciences 2014, 62, 243-250. 27. Miao, Y.; Qiu, Y.; Yang, W.; Guo, Y.; Hou, H.; Liu, Z.; Zhao, X., Charge reversible and biodegradable nanocarriers showing dual pH-/reduction-sensitive disintegration for rapid site-specific drug delivery. Colloids Surface B: Biointerfaces 2018, 169, 313-320. 28. Rao, Z.; Ge, H.; Liu, L.; Zhu, C.; Min, L.; Liu, M.; Fan, L.; Li, D., Carboxymethyl cellulose modified graphene oxide as pH-sensitive drug delivery system. International Journal of Biological Macromolecules 2018, 107, 1184-1192. 29. Yang, C.; Xue, Z.; Liu, Y.; Xiao, J.; Chen, J.; Zhang, L.; Guo, J.; Lin, W., Delivery of anticancer drug using pH-sensitive micelles from triblock copolymer MPEG-b-PBAE-b-PLA. Materials Science and Engineering 2018, 84, 254-262. 30. Almurshedi, A. S.; Radwan, M.; Omar, S.; Alaiya, A. A.; Badran, M. M.; Elsaghire, H.; Saleem, I. Y.; Hutcheon, G. A., A novel pH-sensitive liposome to trigger delivery of afatinib to cancer cells: Impact on lung cancer therapy. Journal of Molecular Liquids 2018, 259, 154-166. 31. Giansanti, L.; Mauceri, A.; Galantini, L.; Altieri, B.; Piozzi, A.; Mancini, G., Glucosylated pH-sensitive liposomes as potential drug delivery systems. Chemistry and Physics of Lipids 2016, 200, 113-119. 32. Chang, D.; Gao, Y.; Wang, L.; Liu, G.; Chen, Y.; Wang, T.; Tao, W.; Mei, L.; Huang, L.; Zeng, X., Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy. Journal of Colloid and Interface Science 2016, 463, 279-287. 33. Yang, H.; Tang, C.; Yin, C., Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer. Acta Biomaterialia 2018, 73, 400-411. 34. Avedian, N.; Zaaeri, F.; Daryasari, M. P.; Javar, H. A.; Khoobi, M., pH-sensitive biocompatible mesoporous magnetic nanoparticles labeled with folic acid as an efficient carrier for controlled anticancer drug delivery. Journal of Drug Delivery Science Technology 2018, 44, 323-332. 35. Dabiri, S. M. H.; Lagazzo, A.; Barberis, F.; Shayganpour, A.; Finocchio, E.; Pastorino, L., New in-situ synthetized hydrogel composite based on alginate and brushite as a potential pH sensitive drug delivery system. Carbohydrate Polymers 2017, 177, 324-333. 36. Demirdirek, B.; Uhrich, K. E., Novel salicylic acid-based chemically crosslinked pH-sensitive hydrogels as potential drug delivery systems. International Journal of Pharmaceutics 2017, 528 (1-2), 406-415. 37. Zhao, T.; Maniglio, D.; Chen, J.; Chen, B.; Migliaresi, C., Development of pH-sensitive self-nanoemulsifying drug delivery systems for acid-labile lipophilic drugs. Chemistry and Physics of Lipids 2016, 196, 81-88. 38. Hossieni-Aghdam, S. J.; Foroughi-Nia, B.; Zare-Akbari, Z.; Mojarad-Jabali, S.; Farhadnejad, H., Facile fabrication and characterization of a novel oral pH-sensitive drug delivery system based on CMC hydrogel and HNT-AT nanohybrid. International Journal of Biological Macromolecules 2018, 107, 2436-2449. 39. Luan, J.; Wu, K.; Li, C.; Liu, J.; Ni, X.; Xiao, M.; Xu, Y.; Kuang, Y.; Jiang, F., pH-sensitive drug delivery system based on hydrophobic modified konjac glucomannan. Carbohydrate Polymers 2017, 171, 9-17. 40. Chen, S.; Yang, Y.; Li, H.; Zhou, X.; Liu, M., pH-Triggered Au-fluorescent mesoporous silica nanoparticles for 19F MR/fluorescent multimodal cancer cellular imaging. Chemical Communications 2014, 50 (3), 283-285. 41. Cui, L.; Lin, H.; Yang, C.; Han, X.; Zhang, T.; Qu, F., Synthesis of multifunctional Fe3O4@mSiO2@Au core–shell nanocomposites for pH‐responsive drug delivery. European Journal of Inorganic Chemistry 2014, 2014 (36), 6156-6164. 42. Dai, L.; Zhang, Q.; Shen, X.; Sun, Q.; Mu, C.; Gu, H.; Cai, K., A pH-responsive nanocontainer based on hydrazone-bearing hollow silica nanoparticles for targeted tumor therapy. Journal of Materials Chemistry B 2016, 4 (26), 4594-4604. 43. Kim, M. S.; Jeon, J. B.; Chang, J. Y., Selectively functionalized mesoporous silica particles with the PEGylated outer surface and the doxorubicin-grafted inner surface: Improvement of loading content and solubility. Microporous and Mesoporous Materials 2013, 172, 118-124. 44. Lee, C. H.; Cheng, S. H.; Huang, I. P.; Souris, J. S.; Yang, C. S.; Mou, C. Y.; Lo, L. W., Intracellular pH‐responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angewandte Chemie International Edition 2010, 49 (44), 8214-8219. 45. Lin, C. H.; Cheng, S. H.; Liao, W. N.; Wei, P. R.; Sung, P. J.; Weng, C. F.; Lee, C. H., Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin. International Journal of Pharmaceutics 2012, 429 (1-2), 138-147. 46. Zhang, P.; Kong, J., Doxorubicin-tethered fluorescent silica nanoparticles for pH-responsive anticancer drug delivery. Talanta 2015, 134, 501-507. 47. Chen, M.; He, X.; Wang, K.; He, D.; Yang, S.; Qiu, P.; Chen, S., A pH-responsive polymer/mesoporous silica nano-container linked through an acid cleavable linker for intracellular controlled release and tumor therapy in vivo. Journal of Materials Chemistry B 2014, 2 (4), 428-436. 48. Chen, T.; Yu, H.; Yang, N.; Wang, M.; Ding, C.; Fu, J., Graphene quantum dot-capped mesoporous silica nanoparticles through an acid-cleavable acetal bond for intracellular drug delivery and imaging. Journal of Materials Chemistry B 2014, 2 (31), 4979-4982. 49. Liu, R.; Zhang, Y.; Zhao, X.; Agarwal, A.; Mueller, L. J.; Feng, P., pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. Journal of the American Chemical Society 2010, 132 (5), 1500-1501. 50. Schlossbauer, A.; Dohmen, C.; Schaffert, D.; Wagner, E.; Bein, T., pH‐Responsive release of acetal‐linked melittin from SBA‐15 mesoporous silica. Angewandte Chemie International Edition 2011, 50 (30), 6828-6830. 51. Yang, K.; Luo, H.; Zeng, M.; Jiang, Y.; Li, J.; Fu, X., Intracellular pH-triggered, targeted drug delivery to cancer cells by multifunctional envelope-type mesoporous silica nanocontainers. ACS Applied Materials Interfaces 2015, 7 (31), 17399-17407. 52. Chen, H.; Zheng, D.; Liu, J.; Kuang, Y.; Li, Q.; Zhang, M.; Ye, H.; Qin, H.; Xu, Y.; Li, C., pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles. International Journal of Biological Macromolecules 2016, 85, 596-603. 53. Chen, L.; Zhang, Z.; Yao, X.; Chen, X.; Chen, X., Intracellular pH-operated mechanized mesoporous silica nanoparticles as potential drug carries. Microporous and Mesoporous Materials 2015, 201, 169-175. 54. Liu, J.; Luo, Z.; Zhang, J.; Luo, T.; Zhou, J.; Zhao, X.; Cai, K., Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy. Biomaterials 2016, 83, 51-65. 55. Wang, J.; Liu, H.; Leng, F.; Zheng, L.; Yang, J.; Wang, W.; Huang, C. Z., Autofluorescent and pH-responsive mesoporous silica for cancer-targeted and controlled drug release. Microporous and Mesoporous Materials 2014, 186, 187-193. 56. Wang, T. T.; Lan, J.; Zhang, Y.; Wu, Z. L.; Li, C. M.; Wang, J.; Huang, C. Z., Reduced graphene oxide gated mesoporous silica nanoparticles as a versatile chemo-photothermal therapy system through pH controllable release. Journal of Materials Chemistry B 2015, 3 (30), 6377-6384. 57. Xiao, D.; Jia, H. Z.; Zhang, J.; Liu, C. W.; Zhuo, R. X.; Zhang, X. Z., A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery. Small 2014, 10 (3), 591-598. 58. Yang, Y.; Achazi, K.; Jia, Y.; Wei, Q.; Haag, R.; Li, J., Complex assembly of polymer conjugated mesoporous silica nanoparticles for intracellular pH-responsive drug delivery. Langmuir 2016, 32 (47), 12453-12460. 59. Aznar, E.; Marcos, M. D.; Ramon, M. M.; Sancenón, F.; Soto, J.; Amorós, P.; Guillem, C., pH-and photo-switched release of guest molecules from mesoporous silica supports. Journal of the American Chemical Society 2009, 131 (19), 6833-6843. 60. Chen, X.; Yao, X.; Wang, C.; Chen, L.; Chen, X., Mesoporous silica nanoparticles capped with fluorescence-conjugated cyclodextrin for pH-activated controlled drug delivery and imaging. Microporous and Mesoporous Materials 2015, 217, 46-53. 61. Denizá Yilmaz, M.; Fraserá Stoddart, J., Esterase-and pH-responsive poly (β-amino ester)-capped mesoporous silica nanoparticles for drug delivery. Nanoscale 2015, 7 (16), 7178-7183. 62. Gan, Q.; Lu, X.; Yuan, Y.; Qian, J.; Zhou, H.; Lu, X.; Shi, J.; Liu, C., A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica. Biomaterials 2011, 32 (7), 1932-1942. 63. Li, D.; Huang, X.; Wu, Y.; Li, J.; Cheng, W.; He, J.; Tian, H.; Huang, Y., Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug. Biomaterials Science 2016, 4 (2), 272-280. 64. Luo, Z.; Cai, K.; Hu, Y.; Zhang, B.; Xu, D., Cell‐specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity. Advanced Healthcare Materials 2012, 1 (3), 321-325. 65. Qiu, X. L.; Li, Q. L.; Zhou, Y.; Jin, X. Y.; Qi, A. D.; Yang, Y. W., Sugar and pH dual-responsive snap-top nanocarriers based on mesoporous silica-coated Fe3O4 magnetic nanoparticles for cargo delivery. Chemical Communications 2015, 51 (20), 4237-4240. 66. Tan, L.; Yang, M. Y.; Wu, H. X.; Tang, Z. W.; Xiao, J. Y.; Liu, C. J.; Zhuo, R. X., Glucose-and pH-responsive nanogated ensemble based on polymeric network capped mesoporous silica. ACS Applied Materials Interfaces 2015, 7 (11), 6310-6316. 67. Yilmaz, M. D.; Xue, M.; Ambrogio, M. W.; Buyukcakir, O.; Wu, Y.; Frasconi, M.; Chen, X.; Nassar, M. S.; Stoddart, J. F.; Zink, J. I., Sugar and pH dual-responsive mesoporous silica nanocontainers based on competitive binding mechanisms. Nanoscale 2015, 7 (3), 1067-1072. 68. Yan, Y.; Fu, J.; Liu, X.; Wang, T.; Lu, X., Acid-responsive intracellular doxorubicin release from click chemistry functionalized mesoporous silica nanoparticles. RSC Advances 2015, 5 (39), 30640-30646. 69. Zhang, J.; Wu, D.; Li, M. F.; Feng, J., Multifunctional mesoporous silica nanoparticles based on charge-reversal plug-gate nanovalves and acid-decomposable ZnO quantum dots for intracellular drug delivery. ACS Applied Materials Interfaces 2015, 7 (48), 26666-26673. 70. Maltser, S.; Cristian, A.; Silver, J. K.; Morris, G. S.; Stout, N. L., A focused review of safety considerations in cancer rehabilitation. PM&R 2017, 9, S415-S428. 71. Kufe, D. W.; Hait, W.; Holland, J. F.; Frei, E.; Pollock, R. E., Holland-Frei Cancer Medicine 2010; Vol. 8. 72. Shevchuk, O.; Posokhova, E.; Sakhno, L.; Nikolaev, V., Theoretical ground for adsorptive therapy of anthracyclines cardiotoxicity. Experimental Oncology 2012, 34, 314-322. 73. Valdes, T.; Kreutzer, D.; Moussy, F., The chick chorioallantoic membrane as a novel in vivo model for the testing of biomaterials. Journal of Biomedical Materials Research 2002, 62 (2), 273-282. 74. Tufan, A.; Satiroglu-Tufan, N., The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents. Current Cancer Drug Targets 2005, 5 (4), 249-266. 75. Lokman, N. A.; Elder, A. S.; Ricciardelli, C.; Oehler, M. K., Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. International Journal of Molecular Sciences 2012, 13 (8), 9959-9970. 76. Dunn, B. E.; Graves, J. S.; Fitzharris, T. P., Active calcium transport in the chick chorioallantoic membrane requires interaction with the shell membranes and/or shell calcium. Developmental Biology 1981, 88 (2), 259-268. 77. Gabrielli, M. G.; Accili, D., The chick chorioallantoic membrane: a model of molecular, structural, and functional adaptation to transepithelial ion transport and barrier function during embryonic development. Journal of Biomedicine and Biotechnology 2010, 1-12. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78604 | - |
dc.description.abstract | 近幾年,奈米材料在生物醫學的應用上受到相當大的重視,由於其高生物相容性、易調控的尺寸大小、利於表面修飾等特性,經常被用來當作藥物或是生物顯影劑的載體。目前,最廣泛使用的奈米材料包含金屬氧化物、奈米碳材、半導體材料等,而本實驗中,將使用中孔洞二氧化矽奈米材料作為主要載體。中孔洞二氧化矽奈米材料擁有相當高的表面積以及可調控的孔洞大小利於搭載藥物,並可利用多種矽烷偶合劑 (silane coupling agent) 來進行表面修飾。此外,酸鹼值敏感型藥物載體的研究日趨增加,由於腫瘤環境較為酸性,可利用酸鹼值的差異來控制藥物釋放。
本研究中,我們將設計一種對酸鹼值敏感的中孔洞二氧化矽奈米材料,以靜電吸附的方式搭載抗癌藥物泛艾黴素(Epirubicin),並利用腫瘤微酸環境的特性,於材料表面修飾對酸鹼值值敏感的官能基進而達到標靶的效果。首先,我們嘗試並成功合成出具有酸鹼值敏感的官能基,且利用一步合成的方式將其修飾在表面,形成一種核-殼的中孔洞二氧化矽奈米材料 (core-shell structure)。為了增加材料的懸浮性以及增加材料在生物體內的循環時間,我們在對酸鹼值敏感的殼層上修飾長碳鏈的有機官能機。當材料經血液循環至腫瘤微酸環境時,由於其酸鹼值敏感的特性,酸鹼值敏感殼層會崩解,使得殼層上的長碳鏈一併掉落,進而讓材料互相聚集,達到累積在腫瘤的效果,並增加細胞吞噬的可能性。此外,我們於材料骨架內修飾具有一級胺及二級胺的官能基來調整材料的表面電荷,使其在中性環境下帶負電並於酸性環境中帶正電,來增加材料對藥物吸附力以及優化藥物釋放效果。 細胞實驗方面,我們使用小鼠乳腺癌細胞 (4T1 cell) 為細胞株。在細胞毒性實驗結果中,酸鹼值敏感的中孔洞二氧化矽奈米材料具有良好的生物相容性,且搭載藥物後對於腫瘤細胞的生長有相當高的抑制效果。此外,其較小的材料尺寸 (約50奈米) 及骨架內修飾的胺基官能基有利於細胞的吞噬,進而在像胞內體 (endosome) 更酸性的胞器中釋放藥物。 動物實驗方面,我們利用雞胚胎尿絨毛膜模型 (chick embryo CAM) 作為動物實驗體。相較於小鼠模型,雞胚胎腫瘤模型花費更少的時間與金錢,且不受數量限制,操作上也較為方便及容易。實驗結果中,酸鹼值敏感的中孔洞二氧化矽奈米材料搭載抗癌藥物具有良好的腫瘤抑制效果,且相對於一般中孔洞二氧化矽奈米材料有更好的標靶性及高滲透長滯留效應 (EPR effect),大大提升材料於生物醫學應用的潛力。 | zh_TW |
dc.description.abstract | In the past decades, nanoparticles have been highly promising in biomedical studies for drug delivery or cell tracking due to their biocompatibility, multifunction, tunable size, and so on. There is a wide variety of nano-materials, including metal oxide, carbon, semiconductors. Among these materials, we will focus on the mesoporous silica nanoparticles (MSNs). Mesoporous silica nanoparticles (MSNs) have gained significant attention in nanomedicine research owing to its high surface area, tunable pore size, easy functionalization, exceptional stability. Besides, pH-responsive nanocarriers have been recently developed to control drug release between healthy areas and the tumor microenvironment.
In this study, we synthesized pHR-MSN-PEG/DA@EPIs, in which pH-responsive (pHR) core-shell MSNs were utilized as nanocarriers, and the anti-tumor drug epirubicin (EPI) was encapsulated by electrical absorption. To promote the application in biomedicine, PEGylation was use to increase the suspension properties of the nanoparticles and enhance circulation time in organisms. Though the PEGylated nanoparticles have well enhanced permeability and retention effect, they are not easily uptaken by cells. Hence, the strategy of designation is that the PEGylated pH-responsive shell degrade and cause a decrease in the suspension properties when the nanoparticles arrives to acidic tumor microenvironment. Due to the degradation of PEGylated pH-responsive shell, the nanoparticles aggregated and accumulated in tumor site, also increasing the cell uptake. Furthermore, we modified the functional groups with primary and secondary amines to control the loading and release of the chemodrug. Test tube studies showed the zeta potential of nanoparticles to be negative in neutral environments, which increased the attraction towards EPI. On the other hand, pHR-MSN-PEG/DA became positively charged under lower pH conditions, and consequently induced drug release. In vitro studies showed that the carrier pHR-MSN-PEG/DA is non-toxic and cellular uptake is pretty facile. Cytotoxicity of pHR-MSN-PEG/DA@EPIs were evaluated in 4T1 cells, showing considerable cytotoxicity towards tumor cells. For in vivo studies, a chicken embryo model was developed, and pHR-MSN-PEG/DA exhibited excellent passive targeting behavior due to permeability and retention (EPR) effect. In a chicken embryo chorioallantoic membrane (CAM) tumor model, pHR-MSN-PEG/DA@EPIs were shown to have potential tumor-targeting ability and strong effects as drug carriers for tumor inhibition. Due to these behaviors, pHR-MSN-PEG/DA@EPIs are promising nanoparticles for chemotherapy. | en |
dc.description.provenance | Made available in DSpace on 2021-07-11T15:06:47Z (GMT). No. of bitstreams: 1 ntu-108-R06223131-1.pdf: 4035496 bytes, checksum: 777388b8aa944f1688faaff00365ce0e (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 致謝 II
摘要 III Abstract V Contents VII List of Figures XI List of Tables XV Chapter 1 General Introduction 1 1.1 Nanoparticles for Cancer Therapy 1 1.2 Introduction of Mesoporous Silica Nanoparticles 2 1.2.1 General Concepts of Mesoporous Silica Nanoparticles 2 1.2.2 Synthesis of Mesoporous Silica Nanoparticles 3 1.2.3 Surface Functionalization of Mesoporous Silica Nanoparticles 6 1.3 Introduction of pH-Responsive Drug Delivery System 7 1.3.1 General Concepts of pH-Responsive Drug Delivery System 7 1.3.2 Different Types of pH-Responsive Drug Delivery System 9 1.4 Cancer Therapeutic Drug 13 1.4.1 General Concepts of Anticancer Drug 13 1.4.2 A General Description of Epirubicin 15 1.5 The Chicken Chorioallantoic Membrane Tumor Model 15 1.6 Motivation and Objectives 19 Chapter 2 Experimental Section 20 2.1 Materials and Methods 20 2.1.1 Chemical and Reagents 20 2.1.2 Characterization of Mesoporous Silica Nanoparticles 21 2.2 Synthetic Procedures 23 2.2.1 Synthesis of pH-Responsive Silane 23 2.2.2 Synthesis of pH-Responsive Core-Shell Mesoporous Silica Nanoparticles 24 2.2.3 Synthesis of Fluorescent pH-Responsive Core-Shell Mesoporous Silica Nanoparticles 25 2.2.4 Synthesis of EPI-Loaded pH-Responsive Core-shell Mesoporous Silica Nanoparticles 26 2.3 In vitro Experiment of pH-Responsive Mesoporous Silica Nanoparticles 27 2.3.1 Drug Release Profile 27 2.3.2 Cell Culture 28 2.3.3 Cellular Uptake 28 2.3.4 Intracellular Imaging 29 2.3.5 Cytotoxicity Assay 30 2.3.6 Western Blot Analysis 31 2.4 In vivo Experiment of pH-Responsive Mesoporous Silica Nanoparticles 32 2.4.1 Intravenous Injection 32 2.4.2 Bio-Distribution 33 2.4.3 Tumor Inhibition 34 Chapter 3 Results and Discussion 35 3.1 Characterization of pH-Responsive Silane 35 3.1.1 NMR Spectrum of pHR-Responsive Silane 36 3.1.2 FT-IR Spectrum of pH-Responsive Silane 38 3.1.3 Mass Spectrum of pH-Responsive Silane 39 3.2 Characterization of pH-Responsive MSN 40 3.2.1 TEM Image and DLS Data 40 3.2.2 BET Analysis and XRD Spectrum 42 3.2.3 Titration Curve of Zeta Potential 44 3.2.4 Degradable pH-Responsive Shell 45 3.3 In vitro Study 46 3.3.1 Drug Loading and Release Profile 46 3.3.2 Cellular Uptake 49 3.3.3 Cell Viability 50 3.3.4 Intracellular Uptake 52 3.4 In vivo Study 54 3.4.1 Bio-Distribution 54 3.4.2 Tumor Inhibition 55 Conclusion 59 Reference 61 | |
dc.language.iso | en | |
dc.title | pH值敏感型中孔洞二氧化矽奈米材料之設計與藥物傳遞應用 | zh_TW |
dc.title | Designing a pH-Responsive Mesoporous Silica Nanoparticle Drug Delivery System | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 葉晨聖(Chen-Sheng Yeh),胡尚秀(Shang-Hsiu Hu) | |
dc.subject.keyword | 中孔洞二氧化矽奈米材料,殼-核結構,酸鹼值敏感,泛艾黴素,乳腺癌細胞,雞胚胎尿絨毛膜動物模型, | zh_TW |
dc.subject.keyword | mesoporous silica nanoparticles,core-shell structure,pH-responsive nanocarrier,epirubicin,chick embryo chorioallantoic membrane tumor model, | en |
dc.relation.page | 66 | |
dc.identifier.doi | 10.6342/NTU201903122 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2019-08-14 | |
dc.contributor.author-college | 理學院 | zh_TW |
dc.contributor.author-dept | 化學研究所 | zh_TW |
顯示於系所單位: | 化學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-R06223131-1.pdf 目前未授權公開取用 | 3.94 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。